Eugene

[email protected]

LATEST

Novartis, Amgen, AstraZeneca Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Novartis, Amgen, and AstraZeneca. Editor’s Note: This article was updated on a continuous basis for news…

UK Parliamentary Committee Voices Concerns on Regulatory Divergence Post Brexit
By

By
The Business, Energy & Industrial Strategy Committee of the UK Parliament has released a report, The Impact of Brexit on the Pharmaceutical Sector, to highlight its concerns over the prospect…

Novo Nordisk Partners for Technology to Manufacture Stem-Cell Lines
By

By
Novo Nordisk has partnered with the University of California San Francisco (UCSF) for technology for generating good manufacturing practice (GMP) human embryonic stem-cell lines. The technology will support Novo Nordisk’s…

Vectalys, VC Firm Form New Gene-Therapy Company FlashCell
By

By
Vectalys, a Toulouse, France-based biotechnology company specializing in lentiviral manufacturing services, and Auriga Partners, a venture-capital firm, have partnered to form FlashCell, a new gene-therapy company specialized in developing RNA…

Novartis CEO Highlights Company’s Growth Strategy
By

By
At a recent investors’ meeting, Novartis CEO Vas Narasimhan highlighted the company’s growth strategy, which includes 10 potential blockbuster launches in the next three years, further investment in gene therapy…

FDA Outlines Plan to Increase Access for Samples for Generic-Drug Testing
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb outlined new efforts by the agency to increase access of samples of branded drugs needed by generic-drug developers for testing. Its…

WuXi Biologics To Build Biomanufacturing Center in China
By

By
WuXi Biologics, part of WuXi AppTec, a contract service provider, plans to build an integrated biologics development, clinical, and commercial manufacturing center in Shijiazhuang, Hebei province, North China. The new…

President Trump Announces Plan on Drug Prices
By

By
In a speech delivered on May 11, 2018, President Donald Trump highlighted his plan for addressing drug pricing in the US, including speeding up the approval process for over-the-counter products,…

Fujifilm Acquires Full Ownership of Toyama Chemical
By

By
Fujifilm Holdings has agreed to acquire its remaining stake in Toyama Chemical, a company developing small-molecule pharmaceutical products, to give it full ownership. Fujifilm Holdings is acquiring the remaining stake…

Novasep Invests $11.8 Million in Fill/Finish for Low-Volume Biologics
By

By
Novasep, a Lyon, France-headquartered contract manufacturer and life-science service provider, has invested EUR 10 million ($11.8 million) in a commercial fill/finish facility for viral vectors, monoclonal antibodies (mAbs), and other…